IntrinsicIntrinsic
← Scroll for more →

Financial Statements — PHIO

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Cash & Equivalents13.0017.0321.0310.7110.7813.285.385.394.706.488.498.4611.369.0911.8314.5318.0720.5124.1126.58
Total Current Assets14.3017.4021.4811.4911.2913.445.745.865.296.859.329.3312.049.4012.4515.3819.6921.6724.7327.45
Property, Plant & Equipment0.010.010.010.010.010.000.000.000.000.000.010.140.160.170.180.200.210.220.130.15
Total Non-current Assets*0.010.010.010.010.010.000.000.000.000.010.040.210.260.300.370.410.460.500.440.49
Total Assets14.3117.4121.4911.5111.3013.445.745.875.306.859.369.5412.309.7112.8115.7920.1422.1625.1727.94
Accounts Payable0.900.260.440.520.240.430.250.180.340.320.660.170.640.900.780.541.150.330.280.32
Total Current Liabilities--------1.211.271.010.921.521.251.632.332.392.401.942.193.042.573.072.50
Long-term Debt------------------------------------0.000.00
Total Non-current Liabilities*--------0.000.000.000.000.000.000.000.000.000.000.040.070.100.140.170.20
Total Liabilities*1.710.951.341.671.211.271.010.921.521.251.632.332.392.401.972.263.142.713.242.70
Retained Earnings(163.19)(159.06)(155.05)(152.68)(150.29)(148.12)(146.36)(144.73)(143.21)(141.36)(139.21)(137.31)(134.53)(131.98)(128.38)(125.65)(122.07)(119.54)(116.90)(113.45)
Total Stockholder Equity12.6016.4620.159.8410.1012.174.724.953.775.607.737.219.907.3110.8413.5317.0019.4521.9325.25
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Research & Development3.082.791.481.181.070.890.990.640.871.151.011.811.382.131.612.511.301.591.802.81
Selling, General & Admin1.191.371.061.321.240.990.690.951.051.060.770.971.161.471.121.061.221.051.660.93
Total Operating Expenses4.274.172.532.512.311.871.671.591.912.211.902.782.553.602.733.572.522.643.453.74
Operating Income(4.27)(4.17)(2.53)(2.50)(2.31)(1.87)(1.67)(1.59)(1.91)(2.21)(1.90)(2.78)(2.55)(3.60)(2.73)(3.57)(2.52)(2.64)(3.45)(3.74)
Net Income(4.14)(4.00)(2.37)(2.39)(2.17)(1.77)(1.63)(1.52)(1.85)(2.15)(1.89)(2.78)(2.55)(3.60)(2.73)(3.58)(2.53)(2.64)(3.45)(3.74)
Basic EPS(0.36)(0.34)(0.15)(0.44)(0.45)(0.41)(3.45)(1.54)(3.62)(0.47)0.56(1.14)(1.47)(3.15)(9.46)(0.26)(0.19)(0.19)----
Diluted EPS--------(0.45)(0.41)(3.45)(1.54)(3.62)(0.47)0.56(1.14)(1.47)(3.15)(9.46)(0.26)(0.19)(0.19)----
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Operating Cash Flow(4.03)(4.00)(2.08)(2.08)(2.54)(1.27)(1.37)(1.95)(1.78)(2.01)(2.37)(2.90)(2.77)(2.71)(2.70)(3.53)(2.43)(3.47)(2.47)(3.10)
Capital Expenditures0.000.000.000.010.000.000.000.000.00--0.000.000.010.000.000.010.010.100.000.03
Free Cash Flow*(4.03)(4.00)(2.08)(2.09)(2.54)(1.28)(1.37)(1.95)(1.78)--(2.37)(2.90)(2.78)(2.71)(2.70)(3.53)(2.44)(3.57)(2.47)(3.13)
Investing Cash Flow0.000.000.00(0.01)-0.00-0.000.010.000.00--0.000.00-0.000.000.00(0.01)(0.01)(0.10)0.00(0.03)
Financing Cash Flow0.000.0012.412.020.049.171.362.650.00-0.002.400.005.05(0.04)0.00-0.000.00(0.02)-0.000.23
← Scroll for more columns →

* Derived from reported values